India reports 2 deaths due to H3N2

STORY: India reports 2 deaths due to H3N2 DATELINE: March 11, 2023 LENGTH: 00:01:31 LOCATION: New Delhi CATEGORY: SOCIETY SHOTLIST: 1. various of India gate 2. various of people moving into crowded market place 3. various of hospital area 4. various of traffic STORYLINE: Two persons have died in India due to the seasonal influenza H3N2 - one in Karnataka state and the other in Haryana state, Indian health authorities confirmed on Friday. Both the deceased were said to be suffering from old age and comorbidities. "A total of 3,038 laboratory-confirmed cases of various subtypes of Influenza, including H3N2, have been reported till March 9 by the states. This includes 1,245 cases in January, 1307 in February and 486 cases in March (till 9th March)," said an official statement issued by the federal Ministry of Health and Family Welfare. It added, "So far, Karnataka and Haryana have confirmed one death each from H3N2 influenza." The federal health ministry is keeping a close watch on the seasonal influe

Peruvians aged 18 and up with pre-existing conditions take 2nd booster

STORY: Peruvians aged 18 and up with pre-existing conditions take 2nd booster DATELINE: June 8, 2022 LENGTH: 0:03:08 LOCATION: Lima CATEGORY: HEALTH SHOTLIST: 1. various of people getting a fourth dose of COVID-19 vaccine 2. SOUNDBITE (Spanish): GIULIANA DEL CASTILLO, Manager of Health and Social Wellness at San Isidro Municipality in Lima, Peru STORYLINE: Peruvians older than 18 years old who suffer from pre-existing conditions or comorbidities in regard to COVID-19 can now go to vaccination sites to take a fourth dose, or a second booster, in order to combat COVID-19. SOUNDBITE (Spanish): GIULIANA DEL CASTILLO, Manager of Health and Social Wellness at San Isidro Municipality in Lima, Peru "Since June 1, we have started vaccination for people who have COVID comorbidities, aged 18 and up. It is important that people come out to get vaccinated in order to strengthen their immune system." According to the health official, it is necessary for those older than 18 years old and who suffer from health vulnerab

Pfizer, Moderna seek FDA's authorization for second COVID-19 booster shots

STORY: Pfizer, Moderna seek FDA's authorization for second COVID-19 booster shots DATELINE: March 19, 2022 LENGTH: 00:02:36 LOCATION: Washington D.C. CATEGORY: HEALTH SHOTLIST: 1. various of the vaccine production line STORYLINE: American biotechnology company Moderna submitted a request to the U.S. Food and Drug Administration (FDA) on Thursday for emergency use authorization (EUA) on a fourth dose of its COVID-19 vaccine for adults 18 years of age and older, who already received a booster dose of any approved or authorized shot. The request to include adults over 18 years of age was made to provide flexibility for the U.S. Centers for Disease Control and Prevention and healthcare providers to "determine the appropriate use of an additional booster dose," including for those at higher risk of COVID-19 due to age or comorbidities, said the company in a statement. Currently a booster dose of the Moderna COVID-19 vaccine at the 50 microgram dose level is authorized by the FDA for emergency use in the Unite